AE Wealth Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-20,010
Closed -$645K 2072
2023
Q1
$645K Buy
+20,010
New +$645K ﹤0.01% 1230